Both in Pharmaceuticals
Genelux vs Milestone Pharmaceuticals
Over the past year GNLX returned −73.5% and MIST returned −60.2%; their daily moves had a correlation of 0.26.
GNLX −73.5% MIST −60.2%Growth of $1, one year, split-adjusted
| Metric | GNLX | MIST |
|---|---|---|
| Price | $2.04 | $0.7318 |
| Market cap | $92.3M | $91.1M |
| Today | −2.86% | −7.32% |
| 1 month | −19.0% | −10.3% |
| 6 months | −25.5% | −60.9% |
| Year to date | −53.2% | −63.8% |
| 1 year | −73.5% | −60.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 94.3% |
| Net margin | — | −5118.8% |
| P/E (TTM) | — | — |
| Price / sales | 11,537.6× | 38.9× |
| Net cash | $18.7M | $111.4M |
| Dividend yield | — | — |
| Volatility (60d) | 65.4% | 73.9% |
| Short % of float | 12.1% | 17.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).